Cargando…

Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial

Detalles Bibliográficos
Autores principales: Xia, Yi, Wang, Li, Ding, Kaiyang, Wu, Jiazhu, Yin, Hua, Hu, Maogui, Shen, Haorui, Liang, Jinhua, Chen, Ruize, Li, Yue, Zhu, Huayuan, Li, Jianyong, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278685/
https://www.ncbi.nlm.nih.gov/pubmed/37036911
http://dx.doi.org/10.1097/CM9.0000000000002636
_version_ 1785060528516759552
author Xia, Yi
Wang, Li
Ding, Kaiyang
Wu, Jiazhu
Yin, Hua
Hu, Maogui
Shen, Haorui
Liang, Jinhua
Chen, Ruize
Li, Yue
Zhu, Huayuan
Li, Jianyong
Xu, Wei
author_facet Xia, Yi
Wang, Li
Ding, Kaiyang
Wu, Jiazhu
Yin, Hua
Hu, Maogui
Shen, Haorui
Liang, Jinhua
Chen, Ruize
Li, Yue
Zhu, Huayuan
Li, Jianyong
Xu, Wei
author_sort Xia, Yi
collection PubMed
description
format Online
Article
Text
id pubmed-10278685
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102786852023-06-20 Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial Xia, Yi Wang, Li Ding, Kaiyang Wu, Jiazhu Yin, Hua Hu, Maogui Shen, Haorui Liang, Jinhua Chen, Ruize Li, Yue Zhu, Huayuan Li, Jianyong Xu, Wei Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-04-07 2023-06-20 /pmc/articles/PMC10278685/ /pubmed/37036911 http://dx.doi.org/10.1097/CM9.0000000000002636 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Xia, Yi
Wang, Li
Ding, Kaiyang
Wu, Jiazhu
Yin, Hua
Hu, Maogui
Shen, Haorui
Liang, Jinhua
Chen, Ruize
Li, Yue
Zhu, Huayuan
Li, Jianyong
Xu, Wei
Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
title Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
title_full Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
title_fullStr Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
title_full_unstemmed Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
title_short Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
title_sort chidamide-beac plus autologous stem cell transplantation in high-risk non-hodgkin lymphoma: a phase ii clinical trial
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278685/
https://www.ncbi.nlm.nih.gov/pubmed/37036911
http://dx.doi.org/10.1097/CM9.0000000000002636
work_keys_str_mv AT xiayi chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT wangli chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT dingkaiyang chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT wujiazhu chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT yinhua chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT humaogui chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT shenhaorui chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT liangjinhua chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT chenruize chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT liyue chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT zhuhuayuan chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT lijianyong chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial
AT xuwei chidamidebeacplusautologousstemcelltransplantationinhighrisknonhodgkinlymphomaaphaseiiclinicaltrial